HPC
TDOC icon

HM Payson & Co’s Teladoc Health TDOC Stock Holding History

HM Payson & Co’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-100
Closed -$2.15K – 1010
2023
Q4 		$2.15K Sell
100
-32
-24% -$590 ﹤0.01% 901
2023
Q3 		$2.45K Hold
132
– – ﹤0.01% 920
2023
Q2 		$3.34K Hold
132
– – ﹤0.01% 886
2023
Q1 		$3.42K Sell
132
-50
-27% -$1.34K ﹤0.01% 890
2022
Q4 		$4.3K Hold
182
– – ﹤0.01% 812
2022
Q3 		$5K Hold
182
– – ﹤0.01% 859
2022
Q2 		$6K Sell
182
-50
-22% -$2.12K ﹤0.01% 877
2022
Q1 		$17K Sell
232
-437
-65% -$31.5K ﹤0.01% 777
2021
Q4 		$61K Sell
669
-1,888
-74% -$226K ﹤0.01% 575
2021
Q3 		$324K Sell
2,557
-700
-21% -$102K 0.01% 326
2021
Q2 		$542K Buy
3,257
+699
+27% +$113K 0.01% 263
2021
Q1 		$465K Buy
2,558
+325
+15% +$75.4K 0.01% 280
2020
Q4 		$447K Buy
2,233
+581
+35% +$118K 0.01% 278
2020
Q3 		$362K Buy
1,652
+1,620
+5,063% +$343K 0.01% 281
2020
Q2 		$6K Buy
+32
New +$5.61K ﹤0.01% 786

Other funds holding TDOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

HM Payson & Co's TDOC Position: Q1 2024 in Review

HM Payson & Co sold out of Teladoc Health (TDOC) in Q1 2024, closing a stake of 100 shares — an estimated $2.15K sold.

HM Payson & Co first reported a position in TDOC in Q2 2020 and held it in 15 quarters. The position peaked at $542K in Q2 2021. 426 funds tracked by Wall St. Rank hold TDOC as of Q1 2024.

  • HM Payson & Co reported no remaining Teladoc Health position as of Q1 2024 after selling out during the quarter.
  • HM Payson & Co sold 100 Teladoc Health shares in Q1 2024, an estimated $2.15K.
  • HM Payson & Co first reported a position in Teladoc Health in Q2 2020 and held it in 15 quarters.
  • HM Payson & Co's Teladoc Health position peaked at $542K in Q2 2021.
  • 426 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2024.

Based on HM Payson & Co's 13F filing for Q1 2024, filed 20 Jun 2024.